(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.25%) $79.15
(-0.59%) $2.02
(0.10%) $2 311.90
(0.23%) $26.89
(0.19%) $964.40
(0.02%) $0.932
(-0.06%) $10.99
(0.01%) $0.798
(-0.02%) $91.11
Live Chart Being Loaded With Signals
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States...
Stats | |
---|---|
Today's Volume | 671 888 |
Average Volume | 1.35M |
Market Cap | 3.26B |
EPS | $0 ( 2024-03-28 ) |
Next earnings date | ( $-1.500 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.96 |
ATR14 | $0.0630 (0.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-30 | Mehta Kishan | Buy | 16 592 | Stock Option (Right to Buy) |
2024-04-30 | Heffernan Michael Thomas | Buy | 16 592 | Stock Option (Right to Buy) |
2024-04-30 | Gregory Julia P | Buy | 16 592 | Stock Option (Right to Buy) |
2024-04-30 | Hugin Robert J | Buy | 16 592 | Stock Option (Right to Buy) |
2024-04-30 | Antonijevic Irina | Buy | 16 592 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
97.07 |
Last 99 transactions |
Buy: 15 364 606 | Sell: 259 097 |
Volume Correlation
Biohaven Pharmaceutical Correlation
10 Most Positive Correlations | |
---|---|
THD | 0.906 |
KB | 0.888 |
SHG | 0.882 |
NUVB | 0.877 |
BKF | 0.871 |
MX | 0.866 |
YINN | 0.866 |
RAYC | 0.862 |
HBI | 0.859 |
EDC | 0.858 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Biohaven Pharmaceutical Correlation - Currency/Commodity
Biohaven Pharmaceutical Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-3.37M (0.00 %) |
EPS: | $-5.73 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-3.37M (0.00 %) |
EPS: | $-5.73 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-1.39M (0.00 %) |
EPS: | $-12.75 |
Financial Reports:
No articles found.
Biohaven Pharmaceutical
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 for neuropsychiatric indications; and Verdiperstat, a product for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators